Loading...
Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test
BACKGROUND/OBJECTIVES: Paroxysmal nocturnal haemoglobinuria (PNH) is characterized by intravascular haemolysis with a negative direct antiglobulin test (DAT). Eculizumab is a humanized monoclonal antibody that inhibits complement component C5 and is approved for PNH treatment. Recent publications de...
Na minha lista:
| Udgivet i: | Vox Sang |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5664937/ https://ncbi.nlm.nih.gov/pubmed/21929681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1423-0410.2011.01530.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|